# Innovative Biomarkers in de Novo Parkinson's Disease

> **NCT03940677** · NA · TERMINATED · sponsor: **University Hospital, Grenoble** · enrollment: 43 (actual)

## Conditions studied

- Parkinson's Disease
- Healthy Controls Group - Age and Sex-matched

## Interventions

- **PROCEDURE:** Brain MRI
- **PROCEDURE:** TMS-EEG
- **BEHAVIORAL:** Behavioral and cognitive battery
- **OTHER:** Clinical evaluation and clinical scales

## Key facts

- **NCT ID:** NCT03940677
- **Lead sponsor:** University Hospital, Grenoble
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-04-25
- **Primary completion:** 2021-12-09
- **Final completion:** 2021-12-09
- **Target enrollment:** 43 (ACTUAL)
- **Why stopped:** end of funding support
- **Last updated:** 2022-05-12

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03940677

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03940677, "Innovative Biomarkers in de Novo Parkinson's Disease". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03940677. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*